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ABSTRACT 
Half-sandwich organometallic complexes of curcumin are extensively investigated as 
anticancer compounds. Speciation studies were performed to explore the solution stability of 
curcumin complexes formed with [Rh(5-C5Me5)(H2O)3]2+. Acetylacetone (Hacac), as the 
simplest -diketone ligand bearing (O,O) donor set, was involved for comparison and its 
Ru(6-p-cymene), Ru(6-toluene) complexes were also studied. 1H NMR, UV-visible and 
pH-potentiometric titrations revealed a clear trend of stability constants of the acac 
complexes: Ru(6-p-cymene) > Ru(6-toluene) > Rh(5-C5Me5). Despite this order, the 
highest extent of complex formation is seen for the Rh(5-C5Me5) complexes at pH 7.4. 
Formation constant of [Rh(5-C5Me5)(H2curcumin)(H2O)]+ reveals similar solution stability 
to that of the acac complex. Additionally, structures of two complexes were determined by X-
ray crystallography. The in vitro cytotoxicity of curcumin was not improved by the 
complexation with these organometallic cations. 
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1. Introduction 
The field of anticancer drug research is governed by two main factors: efficacy and 
selectivity. Cisplatin (cis-diammine-dichloridoplatinum(II)) and its derivatives are the leading 
compounds of the metal-based chemotherapeutics [1,2]. They possess high cytotoxicity, 
although their use is limited by acquired resistance and side effects caused by the low 
selectivity [1]. The development of novel compounds based on platinum group metal ions is 
an attractive alternative. The Ru(III)-containing trans-[tetrachlorido(DMSO)(imidazole) 
ruthenate(III)] (NAMI-A) [3] and trans-[tetrachloridobis(1H-indazole)ruthenate(III)] 
(KP1339/IT-139) are considered as the most promising candidates, and the latter complex 
already demonstrated remarkable anticancer activity in a phase I clinical trial [4]. Ru(III) is 
assumed to be activated by reduction giving the impetus for the development of Ru(II) 
compounds. A novel Ru(II) compound, [ruthenium(II)(4,4’-dimethyl-2,2’-bipyridine)2-(2-
(2’,2”:5”,2‴-terthiophene)-imidazo[4,5-f][1,10-phenanthroline)]Cl2 (TLD-1433, 
NCT03053635) has entered clinical trials in 2016 as a photodynamic agent [6]. In the half-
sandwich arrangement Ru(II) is protected from hydrolysis and oxidation by the coordination 
of an aromatic ligand, and faster ligand-exchange processes can be observed [7,8]. The 
assumed mechanism of action of this type of complexes is often connected to their ability to 
bind to biomolecules and/or to their redox properties. [Ru(6-arene)(PTA)Cl2] (RAPTA) 
complexes show in vivo activity combined with low toxicity [9]. The group of [Ru(6-
arene)(1,2-ethylenediamine)Cl]+ (RAED) compounds developed by Sadler et al. also exhibits 
significant anticancer activity [10,11].  
 The congener Os(II), Rh(III) and Ir(III) compounds are paid somewhat less attention, 
although some of their half-sandwich complexes have as high cytotoxicity as cisplatin [7,12]. 
The physico-chemical properties of the [Ru/Os(6-arene)(X,Y)(Z)] and [Rh/Ir(5-
arenyl)(X,Y)(Z)] complexes can be optimized by changing the building blocks, e.g. the arene 
(or arenyl) ring, the bidentate (X,Y) ligand or the co-ligand (Z). 
 Compounds bearing (O,O) donor set are often used as ligands like cyclobutane 
dicarboxylate in carboplatin, or oxalate in oxaliplatin [1]. These ligands are found in carbo-
RAPTA and oxali-RAPTA as well [9]. -diketones are one of the oldest groups of (O,O) 
ligands used in analytical and synthetic approaches and a plenty of their half-sandwich 
complexes were synthesized [13]. The simplest -diketone molecule is acetylacetone (Hacac, 
Chart 1), however there are numerous natural compounds containing this motif such as 
dibenzoylmethane (Glycyrrhiza glabra) [14], gingerols (Zingiber officinale) or curcumin 
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(Curcuma longa) [15,16]. The most attractive property of them is their low toxicity against 
healthy cells and they possess intrinsic anticancer properties [15,16]. 
 
 
 
Chart 1. a) Chemical structures of the investigated (O,O) bidentate ligands: acetylacetone (Hacac) and 
curcumin (H3curc); and b) organometallic half-sandwich triaqua cations. c) General chemical structure 
of the mono complexes formed with (O,O) bidentate ligands. 
 
 Curcumin (H3curc, Chart 1) and its derivatives alone or in combination with metal 
ions have been reported to show significant antitumor activity and induce paraptotic effects on 
cancer cells [17]. Curcumin is able to overcome P-glycoprotein mediated multidrug resistance 
in human cancer cells via the inhibition of this transporter [15,16]. However curcumin has 
very low solubility in water, it is photosensitive and may completely hydrolyse under strongly 
basic conditions [18-20] These features make the solution equilibrium studies fairly difficult. 
The insufficient pharmacokinetic properties of curcumin can be overcome by binding to a 
protein or a metal ion [19-21]. A plethora of curcumin metal complexes was synthesized in 
which the ligand could be stabilized. These complexes are potential photosensitizers for 
photodynamic therapy in cancer treatment [21]. Its half-sandwich Ru(II) complex was tested 
against human cancer cell lines showing moderate activity (IC50 = 13.98-62.33 M) [22]. The 
[Rh(5-C5Me5)(H2curc)(H2O)]+ complex is considered as a delivery system of curcumin since 
its cytotoxicity is similar to that of the ligand itself [23]. The combination of PTA and 
curcumin in half-sandwich organo-metallic complexes could enhance the bioactivity [13]. 
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 Despite the high number of organometallic complexes formed with curcumin and its 
derivatives reported in the literature, the solution stability of this type of compounds was not 
characterized and compared to analogous species. As the metal complexes are generally 
considered as prodrugs and can undergo ligand exchange processes in biofluids, information 
about their solution speciation is needed for understanding of their transformation processes. 
Therefore solution stability, aquation (replacement of the chlorido leaving group by a water 
molecule) and deprotonation processes were already studied in our former works in case of 
half-sandwich complexes containing (pentamethylcyclopentadienyl)-rhodium(III) (Rh(5-
C5Me5)), (p-cymene)ruthenium(II) (Ru(6-p-cym)) and (toluene)ruthenium(II) (Ru(6-tol)) as 
the organometallic fragment and various bidentate ligands [24-29]. Herein our aim was to 
investigate the complex formation of curcumin (H3curc) and acetylacetone (Hacac) with 
[Rh(5-C5Me5)(H2O)3]2+, [Ru(6-p-cym)(H2O)3]2+ and [Ru(6-tol)(H2O)3]2+ organometallic 
cations (Chart 1) using pH-potentiometry, UV-visible (UV-Vis) and 1H NMR spectroscopy. 
Interaction of the acac complexes with human serum albumin (HSA) and cell culture medium 
components was characterized by spectrofluorometry and 1H NMR spectroscopy to reveal the 
possible transformation processes. Effect of the complexation on the in vitro cytotoxicity of 
curcumin was also tested in multidrug resistant Colo 320/MDR-LRP human colonic 
adenocarcinoma cell lines. 
 
 
2. Results and discussion 
 
2.1. Hydrolysis of the organometallic cations and proton dissociation processes of ligands 
For the complete description of the equilibrium processes in the organometallic cation 
‒ ligand systems the hydrolysis constants of the metal ions and the proton dissociation 
constants of the ligands are needed. The hydrolytic behaviour of the organometallic 
[Ru(6-p-cym)(H2O)3]2+ and [Ru(6-tol)(H2O)3]2+ cations has been already studied by 
Buglyó et al. in the presence and in the absence of chloride ions [30]. The fast 
hydrolysis of the aquated organoruthenium cations yields the species [(Ru(6-
arene))2(2-OH)3]+ that becomes predominant at pH > ~4.5 (tol) and ~5 (p-cym). When 
0.2 M KCl was used as the background electrolyte, like in our studies, formation of 
various chlorido and mixed chlorido/hydroxido species as intermediates was found in 
addition to the major hydrolysis product [(Ru(6-arene))2(2-OH)3]+ [31].  
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Table 1. Proton dissociation constants (pKa of the studied ligands and stability constants 
(log K [ML]) of organometallic acatylacetonate complexes and overall stability constant 
(log  [MLH2]) of [Rh(5-C5Me5)(H2curc)(H2O)]+, pKa [ML], pHmax, %ML,max and pM*7.4 
values determined by various methods, and H2O/Cl‒ exchange constants (log K’ [ML]) for 
[Rh(5-C5Me5)(acac)(H2O/Cl)]+/0 {T = 25 C; I = 0.2 M (KCl)}.a 
  Acetylacetone  Curcumin 
 Ru(6-tol) Ru(6-p-cym)b Rh(5-C5Me5) Rh(5-C5Me5) 
    
pKa 
(H3L)d 
7.72 ± 0.06 
pKa (HL)c  8.76 ± 0.01  
pKa 
(H2L)d 
9.54 ± 0.01 
    pKa (HL)d 10.32 ± 0.01 
log K [ML] 
7.93 ± 0.09c 
8.09 ± 0.04e 
8.56 
6.44 ± 0.01c 
6.48 ± 0.01e 
log  
[MLH2] 
25.76 ± 0.04f 
pKa [ML] 9.32 ± 0.03
e — —   
pHmaxg 5.32 5.72 8.08 pHmax
g 7.84 
%ML,maxg 8 35 44 %ML,max
g 48 
pM*7.4h 5.31 5.35 5.45 pM*7.4
h 5.54 
log K’ (H2O/Cl-)i — — 1.11 ± 0.01   
a The overall stability constants of organometallic cation’s hydrolysis products:  
log  [(Ru(6-tol))2(2-OH)2]2+ = ‒6.50, log  [(Ru(6-tol))2(2-OH)3]+ = ‒10.56; log  [(Ru(6-p-
cym))2(2-OH)2]2+ = ‒7.12, log  [(Ru(6-p-cym))2(2-OH)3]+ = ‒11.88; log  [(Rh(5-C5Me5))2(2-
OH)2]2+ = ‒11.12, log  [(Rh(5-C5Me5))2(2-OH)3]+ = ‒19.01 at I = 0.20 M (KCl) taken from Refs. 
[24,30].  
b Taken from Ref. [35].  
c Determined by pH-potentiometric titrations.  
d Determined by UV-Vis titrations at pH = 6.0-11.6.  
e Determined by 1H NMR titrations.  
f Constant for [Rh(5-C5Me5)(H2curc)(H2O)]+ determined by UV-Vis spectrometry at pH = 6.8, 
c(M)/c(L) = 0.0-8.6.  
g Calculated for systems containing c(M) = c(L) = 5 M. pHmax is the pH at which the extent of the 
formation of the metal complexes is the highest and %ML,max is the highest fraction of ML under this 
condition. pM* = -log([M]2++2[M2(2-OH)2]2++2[M2(2-OH)3]+).  
h Calculated for systems containing c(M) = c(L) = 5 M and at pH = 7.4.  
i Determined by UV-Vis spectrometry: c(Cl-) = 0.0-0.3 M, pH = 7.3. 
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Stability constants for the hydrolysis products of [Rh(5-C5Me5)(H2O)3]2+ have 
been reported by our group, namely for [(Rh(5-C5Me5))2(2-OH)2(H2O)2]2+ and 
[(Rh(5-C5Me5))2(2-OH)3]+ dinuclear species [24]. Notably, the hydrolysis of Rh(5-
C5Me5)(H2O)3]
2+ starts at higher pH compared with the Ru(6-arene) species. 
Proton dissociation process of acetylacetone (Hacac) is well-known in the 
literature and the pKa constant determined by pH-potentiometry in this work (Table 1) 
is in a good agreement with the reported values [32]. Acetylacetone has two tautomeric 
forms, namely keto and enol, which are distinguishable in the 1H NMR spectra due to 
the slow exchange processes on the NMR time-scale (Figure S1). The reported 
enol/keto equilibrium constant is log Kenol/keto = 0.21 [32], and a similar constant was 
determined based on our measurements (log Kenol/keto = 0.23 ± 0.02). As a consequence 
the keto form predominates in aqueous solutions in the whole pH range studied. 
Curcumin has the same -diketonato group as Hacac, although the proton 
dissociation occurs not merely in this moiety since the two phenolic hydroxyl groups 
have dissociable protons as well. Only few data can be found for the pKa values of 
these moieties in the literature most probably as a consequence of the low water 
solubility and light-induced decomposition of this compound [33]. Therefore, the 
proton dissociation constants of curcumin were determined by UV-Vis spectroscopy in 
a 95% water/5% ethanol mixture using low concentration (5 M) and individual 
samples kept in dark (see Figure S2). By the deconvolution of the recorded UV-Vis 
spectra three pKa values were calculated (Table 1). Presumably the -diketonato group 
has the lowest pKa, which is actually lower than the same group’s constant in the 
Hacac molecule. The two higher constants belong to the overlapping deprotonation of 
the two 2-methoxyphenolic groups. 
 
2.2. Complex formation equilibria of acac with [Rh(5-C5Me5)(H2O)3]2+ and [Ru(6-
tol)(H2O)3]
2+ 
As studies on the solution speciation of curcumin complexes are aggravated owing to 
the insufficient water solubility and light-sensitivity, acetylacetone, possessing a 
similar coordination mode, served as a water soluble model ligand. The solution 
speciation of the [Ru(6-p-cym)(H2O)3]2+ ‒ acac system was already studied by Bíró et 
al., and they determined the log K [ML] formation constant for the mono complex 
(log K [ML] = 8.56, I = 0.2 M KCl) [35]. (M denotes the organometallic triaqua cation 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
7 
 
in which the aqua ligand are partly replaced by the chlorido ligands and the donor 
atoms of the ligands.) Fernández et al. determined the pKa [ML] constant (9.41) for the 
deprotonation of the coordinated water, although a chloride-free medium was applied 
(I = 0.1 M NaClO4) [36]. 
 
 
Figure 1. a) Chemical structures of compounds present in the [Rh(5-C5Me5)(H2O)3]2+‒ acac system. 
b) 1H NMR spectra of [Rh(5-C5Me5)(H2O)3]2+‒ acac system recorded at pH = 1.9-11.4. Peak 
assignation is shown on the structures of a). (M denotes the organometallic half-sandwich triaqua 
cation. Notably the aqua ligand is partly displaced by chloride.) {c(acac) = 2.0 mM; c([Rh(5-
C5Me5)(H2O)3]2+) = 2.1 mM; solvent: 90% H2O / 10% D2O; T = 25.0 °C; I = 0.2 M (KCl)} 
 
Stability constants of acetylacetonato complexes formed with the other two 
organometallic cations were determined by the combined use of pH-potentiometric and 
1H NMR titrations in the presence of 0.2 M chloride ions. It is worth mentioning that 
complex formation was found to be fairly fast in all cases. In the speciation model 
formation of mono complexes such as [ML] and [ML(OH)] was used based on single 
crystal X-ray diffraction results (vide infra) and the findings on analogous complexes 
of other bidentate (O,O) ligands investigated previously [24,25,35]. Figure 1 shows 1H 
  
  
 
 
 
 
 
 
 
   
 
 
⃰
[M2(OH)3]
[ML]
[M]
[HL]oxo
[HL]enol
[L]
[ML]
[ML]
5.8 5.6 5.4 3.9 2.2 2.0 1.8 1.6
a)
b)
 
[HL]enol
11.41
11.04
10.57
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9.50
9.30
9.02
8.46
6.83
5.64
5.04
4.54
3.93
3.44
1.92
pH
  
    ⃰ ⃰ 
d (ppm)
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NMR spectra recorded for the [Rh(5-C5Me5)(H2O)3]2+ ‒ acac system in the pH range 
from 1.9 to 11.4. At acidic pH range (pH < 3.5) only the peaks of the free 
organometallic ion and free ligand (in both the keto and enol forms) can be identified. 
In the pH range 3.5-10.0 a new set of signals appears which is related to the formation 
of complex [Rh(5-C5Me5)(L)(H2O)]+ that predominates at physiological pH (in which 
H2O is partly replaced by Cl
‒). 
On the other hand in case of the [Ru(6-tol)(H2O)3]2+ ‒ acac system, formation 
of mixed hydroxido complex [Ru(6-tol)(acac)(OH)] can be also detected at pH > 8 
(Figure S3,a). The aqua and hydroxido complexes are in equilibrium with high 
exchange rates that cannot be resolved in the NMR time scale. Thus the peaks of the 
mono complex are high-field shifted as the pH is increased and draw a sigmoid curve 
(Figure S3,c). This phenomenon allows the determination of pKa [ML] constant from 
the change of the chemical shifts (Table 1). As the signals assigned to free and bound 
acac ligand as well as to the unbound and bound organometallic fragment appear 
separately in the 1H NMR spectra the integrated peak areas could be converted to 
molar fractions. Based on the molar fractions at the different pH values stability 
constants (log K [ML]) were computed for the [Ru(6-tol)(H2O)3]2+ ‒ acac and [Rh(5-
C5Me5)(H2O)3]
2+ ‒ acac systems (Table 1). They are in a fairly good agreement with 
data determined by pH-potentiometry. In order to compare the stability constants of 
acac complexes to those of other simple (O,O) donor ligands, log K [ML] and 
pKa [ML] values were determined for deferiprone and maltol complexes of Ru(6-tol) 
by pH-potentiometry. (Constants were already reported for deferiprone and maltol 
complexes of Rh(5-C5Me5) and Ru(6-cym) [24,25,35].) The log K [ML] for the 
deferiprone Ru(6-tol) complex is 11.74 ± 0.08 and pKa [ML] is 9.34 ± 0.09. While in 
the [Ru(6-tol)(H2O)3]2+ ‒ maltol system only one constant, log K [ML] = 8.97 ± 0.01 
was determined. The trend of the log K [ML] constants of the acac species is the 
following: [Ru(6-p-cym)(acac)(H2O)]+ > [Ru(6-tol)(acac)(H2O)]+ >> [Rh(5-
C5Me5)(acac)(H2O)]
+, which is the same trend as seen with other (O,O) donor ligands 
such as maltol [24,35] and deferiprone [25,35]. To compare the apparent solution 
stability of the acac complexes pM* values were computed and plotted against the pH 
(Figure 2). pM* value, which is defined as the negative logarithm of the equilibrium 
concentrations of the unbound metal ion (in all forms: triaqua cation and -hydroxido 
dinuclear species) under the given conditions (pH, total concentrations of the ligand 
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and metal ion). Notably, pM was introduced by Raymond et al. [37] to compare the 
relative affinities of ligands towards a given metal ion. Therefore, a higher pM* value 
reflects the stronger metal binding ability of the ligand. Due to the stronger tendency of 
[Ru(6-arene)(H2O)3]2+ cations to undergo hydrolysis at physiological pH compared to 
that of [Rh(5-C5Me5)(H2O)3]2+ [24,30], the highest extent of complex formation is 
found in the [Rh(5-C5Me5)(H2O)3]2+ ‒ acac system under the same conditions (Figure 
2). Table 1 also contains the % [ML] at these pH values and the pM*7.4 values. 
 
 
Figure 2. Calculated pM*-curves obtained for the organometallic cation ‒ acac systems plotted 
against the pH. M = [Rh(5-C5Me5)(H2O)3]2+ (-∙∙-∙∙-); [Ru(6-p-cym)(H2O)3]2+ (‒‒) [35]; [Ru(6-
tol)(H2O)3]2+ (- - -). {c(acac) = c(M) = 5 M; T = 25.0 °C; I = 0.2 M (KCl)} 
 
2.3. Complex formation equilibrium of curcumin with [Rh(5-C5Me5)(H2O)3]2+ 
Concentrations necessary for pH-potentiometric and 1H NMR titrations cannot be 
reached in pure water in case of curcumin. As curcumin has very intensive colour, UV-
Vis spectrophotometric titrations were performed in 95% water/5% ethanol mixture. 
Stock solution was prepared before the measurements by dissolving curcumin in 
ethanol and then stored in the dark. In ethanol the hydrolysis of curcumin does not 
occur [18]. In case of [Ru(6-p-cym)(H2O)3]2+ and [Ru(6-tol)(H2O)3]2+ the spectral 
changes showed that their curcumin complexes have even lower solubility than 
curcumin itself leading to precipitation. Therefore, stability constants for the Ru(6-
arene) complexes could not be obtained under these conditions. In order to determine 
the stability constant for the [Rh(5-C5Me5)(H2curc)(H2O)]+ complex known amounts 
of the organometallic cation were added to the ligand and UV-Vis spectra were 
recorded while the pH was kept constant (pH 6.8) using phosphate buffer (Figure S4.). 
During the titration organorhodium cation was added to curcumin at a maximum of 9-
5.30
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fold excess. Formation of a [Rh(5-C5Me5)(H2curc)(H2O)]+ complex is assumed as the 
deprotonation of the non-coordinating 2-methoxyphenolic groups under these 
conditions is not probable based on the pKa values of curcumin. Since the 
determination of the stability constants of the organoruthenium complexes of curcumin 
failed, it is an interesting point to check how good binding model is acac for curcumin. 
The stability constants determined for the complexes of acac and curcumin cannot be 
compared directly due to the different deprotonation processes of the ligands. Thus, 
concentration distribution curves for the [Rh(5-C5Me5)(H2O)3]2+ ‒ acac and [Rh(5-
C5Me5)(H2O)3]
2+ ‒ curcumin systems are represented in Figure 3. It can be concluded 
that the curves run rather close to each other for both systems, however the curcumin 
complex shows a slightly higher stability. Therefore, acac is not a perfect but an 
adequate binding model ligand for the solution speciation studies of curcumin 
complexes. 
 
 
Figure 3. Calculated concentration distribution curves of [Rh(5-C5Me5)(H2O)3]2+ ‒ acac (dashed 
lines) and [Rh(5-C5Me5)(H2O)3]2+ ‒ curcumin (solid lines) systems based on the stability constants 
from Table 1. {c(M) = c(acac) = c(curcumin) = 5 M; T = 25.0 °C; I = 0.2 M (KCl)} 
 
The solution stability of the studied half-sandwich Rh(5-C5Me5) complexes of 
acac and curcumin was compared to that of (O,O) donor bearing ligands such as maltol 
[24], allomaltol [24] or deferiprone [25] via the calculation of pM* values at various 
pH values (Figure 4). It can be concluded that curcumin and acac form complexes with 
lower stability than the other ligands with 5-membered chelate ring. 
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Figure 4. Calculated pM*-curves of [Rh(5-C5Me5)(H2O)3]2+ ‒ (O,O) bidentate ligand systems 
plotted against the pH. Notations for the various ligands: acac (- - -); curcumin (‒); allomaltol 
[24] (-∙-∙-); maltol [24] (-∙∙-∙); deferiprone [25] (---). pM* = –log([M] + 2[M2(OH)3] + 
2[M2(OH)2]), where M denotes the triaqua organometallic cation. Notably the coordinated H2O 
is partly replaced by Cl‒ in the complexes in the presence of the chloride ions. {c(M) = 
c(L) = 5 mM; T = 25.0 °C; I = 0.2 M (KCl)} 
 
2.4. Structural studies on organometallic Rh(III) and Ru(II) complexes 
Single crystals were obtained for metal complexes Ru(6-tol)(acac)Cl] (1) and [Rh(5-
C5Me5)(H2curc)Cl] × 2MeOH (2) by the reaction of the ligands deprotonated by 
sodium methoxide and the corresponding organometallic dimer precursors. The 
dimeric ruthenium precursor [Ru(6-tol)(2-Cl)Cl]2 was prepared according to 
literature procedures by the reaction of RuCl3×3H2O with 1-methyl-1,4-
cyclohexadiene [38], while [Rh(5-C5Me5)(2-Cl)Cl]2 is commercially available. The 
mixtures of the ligands and the precursors were refluxed for 4 h and then the solvent 
was removed. The complex was dissolved and extracted with CH2Cl2. Single crystals 
of the acac complex were grown in concentrated methanolic solutions. In the case of 
the [Rh(5-C5Me5)(H2curc)(Cl)] complex crystals were obtained from a mixture of 
MeOH/CH2Cl2.  
The [Ru(6-tol)(acac)(Cl)] complex was crystallized without any remaining 
solvent molecule, while Rh(5-C5Me5)(H2curc)(Cl)] crystallized with two methanol 
molecules in the asymmetric unit. The ORTEP representation of the complexes 
showing the atom and ring labels is depicted in Figure 5. The complexes crystallized in 
the monoclinic and in the orthorombic crystal system, in space group P21/c and Pbcn, 
respectively. Selected bond distances and angles are collected in Table 2, structure 
refinement and crystal data are shown in Table S1. The geometry of the complexes are 
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pseudo-tetrahedral: they show the so-called three-legged ‘piano-stool’ geometry 
similarly to the previously determined complexes with bidentate (O,O) and Cl‒ donor 
groups [22,24,25,36,39]. Additional information about hydrogen bonds and packing 
arrangements in crystal 1 is collected in Table S2 and Figs. S5 and S6.  
 
 
Figure 5. a) Molecular structures of [Ru(6-tol)(acac)(Cl)] (1) and b) [Rh(5-C5Me5)(H2curc)(Cl)] × 
2MeOH (2) with labels on rings. Displacement parameters are drawn at 50% probability level; solvent 
molecules are omitted for clarity. 
 
The curcumin molecule is coordinated via its deprotonated acac oxygens (O1 
and O2) forming a six-membered chelate ring with the Rh(III) ion. The metal-O 
distances and bite angles in these complexes are close to the values found in the 
analogous [Ru(6-p-cym)(acac)(Cl)] (2.074 Å, 88.0°) [36] and [Ru(6-p-
cym)(H2curc)(Cl)] [22] (2.071 Å, 87.4°) structures. These data show that acac is a 
good structural model of curcumin. On the other hand, the replacement of the arene 
moiety from p-cymene to toluene does not result in measurable effect on bond lengths 
and angles. The distance between the centre of gravity of the C5Me5 ring (ring A) and 
the Rh centre is 1.7485(15) Å, which falls within the range obtained for relevant Rh 
complexes (1.730-1.759 Å) [24,25,39-45]. In the complex with the heavier congener 
iridium ([Ir(5-C5Me5)(acac)(Cl)]) this distance is found to be 1.753 Å and the bite 
angle is 87.5°, which is slightly different. However, the metal-O distance is 2.100 Å, 
which is longer than in the Rh and Ru complexes [45]. 
 
B
C
D
O1
O2
Cl
Rh
A
O1
O2
Cl
Ru
a) b)
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Table 2. Selected bond distances (Å) and angles (°) of the metal complexes [Ru(6-
tol)(acac)Cl] (1) and [Rh(5-C5Me5)(H2curc)Cl] × 2MeOH (2) a 
 
[Ru(6-
tol)(acac)Cl] (1) 
[Rh(5-C5Me5)(H2curc)Cl] × 
2MeOH (2) 
Bond lengths (Å)   
M—Cgb 1.415(10) 1.7485(15) 
M—O1 2.073(4) 2.083(2) 
M—O2 2.073(4) 2.073(2) 
M—Cl 2.413(2) 2.4630(9) 
   
Angles (°)   
O1—M—O2 88.2(2) 89.72(8) 
O1—M—Cl 85.7(2) 87.08(7) 
O2—M—Cl 84.4(1) 83.99(7) 
a Uncertainties (SD) of the last digits are shown in parentheses.  
b Cg is the centre of gravity calculated for different rings. 
 
The two phenolic oxygens O3 and O5 remained protonated in [Rh(5-
C5Me5)(H2curc)Cl]. The curcumin molecule has a slightly bended conformation. The 
methoxy groups of the two 4-hydroxy-3-methoxyphenyl rings (ring C and D) are 
turned in opposite positions and the angle between the plain of the two rings is 
15.32(15)°. The molecule is not symmetrically bended, ring B and C are almost in 
plane (the angle between their plains is 3.95(16)°), while higher angle could be 
measured between the plains of rings B and D (11.52(15)°). On Figure S7 different 
views of packing arrangement in crystal 2 are shown. Figure S8 shows the crystal-
stabilizing hydrogen bond system and intermolecular distances are collected in Table 
S3. 
Though the analogous Ru(II)-chlorido complex of curcumin was already 
crystallized [22], this is the first structure with its Rh(III) analogue. Figure 6 shows the 
comparison in the molecular conformations in crystal 2 with those of [Ru(6-
cym)(H2curc)(Cl)] × H2O (Ref. code GESYAG) [22] and [Ru(6-
cym)(dimethylH2curc)(Cl)] × CHCl3 × H2O (Ref. code RESXUI) [46] where two 
molecules are in the asymmetric unit. It is clearly seen that the curcumin molecules can 
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adopt very different conformations and bending of the rings C and D can be even 
higher than in crystal 2 (see Table 3). 
 
 
Figure 6. Comparison of molecular structure of [Rh(5-C5Me5)(H2curc)(Cl)] (2) (coloured by 
element) with [Ru(6-cym)(H2curc)(Cl)] (pink) (Ref. code GESYAG) [22] and the two 
molecules in the asymmetrical unit of [Ru(6-cym)(dimethylH2curc)(Cl)] (dark and light 
green) (Ref. code RESXUI) [46]. Ru/Rh ions with the two oxygen and the chlorido ligands are 
superimposed. 
 
Table 3. Comparison of the angles between curcumin ring planes in crystals [Rh(5-
C5Me5)(H2curc)(Cl)], [Ru(6-cym)(H2curc)(Cl)] [22] and [Ru(6-cym)(dimethylH2curc)(Cl)] [46]. 
 [Rh(5-C5Me5) 
(H2curc)(Cl)] 
[Ru(6-cym) 
(H2curc)(Cl)] 
[Ru(6-cym)(dimethylH2curc)(Cl)] 
coloured by element pink dark green light green 
AB (°) 67.8 51.7 66.0 69.2 
BC (°) 4.0 8.1 11.8 47.5 
BD (°) 11.5 13.2 14.7 38.5 
 
 
2.5. H2O/Cl
- exchange in [Rh(5-C5Me5)(acac)(H2O)]+ 
In the crystal structures of the studied half-sandwich organometallic complexes the 
coordination sphere of Ru(II) and Rh(III) contains the arene or arenyl group, the (O,O) 
donor bidentate and a chlorido ligand. While dissolving the complex in water, the good 
leaving group Cl‒ can be substituted by a water molecule. It is considered as an 
important activation step according to the mechanism of action of similar complexes 
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[47], since the chlorido complex is suggested to be less reactive and charge neutral. 
Notably, the chloride ion concentration changes in biofluids: in the blood serum it is 
100 mM, 23 mM in the cytoplasm and 4 mM in the nucleus [47]. The ratio of the aqua 
and chlorido complexes is changing as the compound reaches the nucleus from blood 
and this ratio is governed by the rate of the exchange process and log K’ (H2O/Cl-) 
constant. 
Based on the 1H NMR spectra, in the case of Ru(6-p-cymene) and Ru(6-
toluene) there is no pH range where only the acac complex is present in solution at 
2 mM concentration. Therefore, this constant was determined only for the [Rh(5-
C5Me5)(acac)(H2O)]
+ complex at pH = 7.30 spectrophotometrically, using the same 
approach as in our previous works [24-29]. The water/chloride exchange was found to 
be fast, equilibrium could be reached within few minutes. In Figure 7 the spectral 
changes are clearly seen as the chloride ion concentration is increasing and the 
presence of one isobestic point proves the equilibrium between two species.  
 
 
Figure 7. UV-Vis absorption spectra of [Rh(5-C5Me5)(acac)(H2O)]+ in the presence of chloride ions 
at different concentrations. {c([Rh(5-C5Me5)(H2O)3]2+) = c(acac) = 1 mM; c(Cl-) = 0 - 300 mM; pH = 
7.30 (phosphate buffer); T = 25.0 °C}  
 
The log K’ (H2O/Cl-) constant is determined as 1.11 ± 0.03 (for fitting of the 
absorbance values see Figure S9), that reflects a moderate chloride ion affinity of the 
complex. Comparing this value to those of similar (O,O) donor bearing ligands’ 
complexes e.g. maltol (1.17) [24], allomaltol (1.38) [24], deferiprone (0.78) [25], they 
are quite similar to each other, which means a relatively weak chloride ion affinity. 
Based on this constant it can be predicted that 56%, 23% and 5% is the fraction of the 
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chlorido species at 1 mM concentration of the complex and at physiological pH in 
blood serum, cytoplasm and nucleus, respectively. 
 
2.6. In vitro cytotoxicity and interaction with proteins 
Curcumin and its complexes were tested as anticancer compounds in a human colonic 
adenocarcinoma cell line Colo 320/MDR-LRP multidrug resistant overexpressing 
ABCB1 (MDR1)-LRP, using the thiazolyl blue tetrazolium bromide (MTT) method. 
Literature data reveal that [Ru(6-p-cym)(H2curc)Cl] showed moderate cytotoxicity on 
HCT116 colon adenocarcinoma cell line (IC50 = 13.98 M) [22]. [Rh(5-
C5Me5)(H2curc)Cl] possesses a similar activity as curcumin itself on A549 lung 
adenocarcinoma cells and the complex seems to be a delivery system of curcumin [23]. 
Herein the in vitro cytotoxicity studies of curcumin in the absence and in the presence 
of the various organometallic cations were carried out and IC50 values (after 24 h 
incubation) are collected in Table 4.  
 
Table 4. In vitro cytotoxicity (IC50 values in mM in Colo 320 human colon cancer cell lines) of 
curcumin and its complexes (24 h exposure). 
 IC50 (M) 
Curcumin + Ru(6-tol)(H2O)3]2+ 82.3 ± 1.5 
Curcumin + Ru(6-p-cym)(H2O)3]2+ 63.1 ± 3.6 
Curcumin + Rh(5-C5Me5)(H2O)3]2+ 34.8 ± 0.2 
Curcumin  39.6 ± 2.4 
 
Data reveal that curcumin and its premixed Rh(5-C5Me5) complex have similar 
cytotoxic effect, while for the premixed organoruthenium complexes lower bioactivity 
was determined. Based on these values the free curcumin is effective alone, while 
complexation with [Rh(5-C5Me5)(H2O)3]2+ does not disturb this effect, although 
complex formation with [Ru(6-p-cymene)(H2O)3]2+ and [Ru(6-toluene)(H2O)3]2+ 
interferes with it. To understand better the findings of the in vitro cytotoxic 
measurements the effect of the cell culture medium components on complex stability 
was studied. Cancer cells were grown in a cell culture medium RPMI 1640 
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supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 100 mM 
HEPES. This modified medium contains different inorganic salts, amino acids and 
some other small biomolecules, e.g. folic acid and choline chloride from RPMI 1640 
and various serum proteins from FBS. The serum components have effects on stability 
of both curcumin and its complex, since the hydrolytic stability of curcumin is 
increasing [19,20], however the coordination of amino acid side chains can cause 
decomposition of the original metal complex [28]. Interaction of [Rh(5-
C5Me5)(acac)(H2O)]
+ and RPMI 1640 components with and without FBS was 
monitored by 1H NMR spectroscopy (Figure 8).  
 
 
Figure 8. 1H NMR spectra recorded for [Rh(5-C5Me5)(acac)(H2O)]+ in RPMI 1640 and RPMI 
1640 with 10% FBS media. a) [Rh(5-C5Me5)(acac)(H2O)]+ in RPMI 1640 with 10% FBS 
medium; b) [Rh(5-C5Me5)(acac)(H2O)]+ in RPMI 1640 medium; c) RPMI 1640 with 10% 
FBS medium; d) RPMI 1640 medium; e) free acac in buffered solution at pH = 7.4 (PBS’); f) 
[Rh(5-C5Me5)(acac)(H2O)]+ in buffered solution at pH = 7.4 (PBS’). Dotted rectangle: C5Me5 
protons at various binding environment; dashed rectangle: free acac methyl groups; solid 
rectangles: His proton. {c([Rh(5-C5Me5)(acac)(H2O)]+) = c(acac) = 1 mM; solvent: 
90% H2O / 10% D2O; T = 25.0 °C; t = 24 h} 
 
The chloride ion content of this medium is ~110 mM, which means that around 56% of 
the complex is chlorinated on the basis of the determined log K’ (H2O/Cl‒) constant. 
The recorded 1H NMR spectra show that the complex dissociates in both media: free 
acac is detected and the organometallic rhodium cation is in different environments, 
most probably His is bound to it. In the FBS modified medium different peaks are seen 
which indicates protein-rhodium interactions. In the case of the organoruthenium 
a)
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c)
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f)
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cations complex decomposition can be detected, but there is no difference in the 
binding environment in the two types of medium (Figures S10 and S11).  
Human serum albumin (HSA) is the main transport protein in blood and 
considered as an useful model protein to examine the protein ‒ metal complex 
interactions. It can bind drug molecules in its binding pockets non-specifically and 
metal ions and complexes through coordinating side chains. Using spectrofluorimetry 
binding close to binding site I (IIA subdomain) can be monitored, as Trp-214 is 
sensitive to the binding in this pocket and it can be selectively excited. The binding of 
curcumin to HSA was already investigated several times by other groups and with 
different methods [48,49]. The binding constant is determined as log K = 5.79 by 
spectrofluorimetry and one curcumin molecule binds to one HSA molecule [50]. 
Binding of [Rh(5-C5Me5)(H2O)3]2+ and [Ru(6-tol)(H2O)3]2+ towards HSA was 
characterized previously in our research group [28,29]. The interaction of HSA and 
[Ru(6-p-cym)(H2O)3]2+ has the same characteristics as in the two other cases. 
Quenching constant (log K’Q) can be calculated based on the emission changes of Trp-
214. In the case of [Ru(6-p-cym)(H2O)3]2+ this value is 5.60 ± 0.01. HSA has high 
metal ion affinity, because it can bind at least 8-fold excess of these cations [28,29]. 
Based on spectrofluorimetric and ultrafiltration experiments the binding of acac to 
HSA was excluded.  
In our experimental setup 1 M of HSA was titrated with the organometallic 
ions and with their acac complexes from 1:1 up to 1:10 HSA-to-metal ion/or complex 
ratio and emission spectra were recorded upon excitation at 295 nm after 24 h waiting 
time. Figure 9 shows the spectral changes as the function of HSA-to-metal 
ion/complex ratio in case of the Ru(6-p-cym) species as representative example. The 
presence of acac results in negligible difference. 
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Figure 9. Fluorescence emission intensity at 340 nm of the HSA ‒ [Ru(6-p-cym)(H2O)3]2+ (◊) and the 
HSA ‒ [Ru(6-p-cym)(acac)(H2O)]+ (■) systems. {lEX = 295 nm; c(HSA) = 1 M; c([Ru(6-
tol)(H2O)3]2+) = c(acac) = 0-10 M; T = 25.0 °C; pH = 7.4 (PBS’ buffer); t = 24 h} 
 
Then ultrafiltration/UV-Vis measurements were performed to reveal in which 
form the acac complexes bind to the protein. We found that free acac appears in the 
filtrate (see Figure S12.) with only a very small amount of complex. Therefore, most of 
the organometallic ions are bound to the protein and the ligand is cleaved, so they 
exhibit a dissociative binding mode. 
 
3. Conclusions  
Curcumin and organometallic half-sandwich complexes are in the focus of attention 
since their anticancer activity is widely reported. The half-sandwich curcumin 
complexes are very attractive drug candidates but limited data are reported about their 
stability in aqueous solution and in biological media. In this work we determined the 
pKa values of curcumin and stability constants of the curcumin complex of [Rh(5-
C5Me5)(H2O)3]
2+ with UV-Vis spectroscopy in aqueous solution and in dark. It was 
found that acetylacetone is not a perfect but still a good binding model for curcumin 
based on the determined stability constants, since [Rh(5-C5Me5)(H2curc)(H2O)]+ 
shows only a bit higher stability than [Rh(5-C5Me5)(acac)(H2O)]+. These complexes 
possess lower stability than other half-sandwich Rh and Ru complexes formed with 
(O,O) bidentate ligands. The trend of the stability constant (log K [ML]) values 
determined is Ru(6-p-cymene) > Ru(6-toluene) > Rh(5-C5Me5), however due to the 
highest hydrolytic stability of [Rh(5-C5Me5)(H2O)3]2+ cation, at physiological pH the 
Rh(5-C5Me5) complex is formed at the highest extent. In the basic pH range, 
decomposition of metal complexes to [M2(OH)3]
+ is observed and formation of mixed 
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hydroxido complex [[Ru(6-tol)(acac)(OH)] is detected. The water/chlorido exchange 
constant provides information about the ratio of aqua and chlorido complexes in 
different biological media at physiological pH. 56%, 23% and 5% were found to be the 
ratio of the chlorido complex in blood serum, cytoplasm and nucleus, respectively at 
1 mM concentration of the [Rh(5-C5Me5)-acac complex.  
The in vitro cytotoxicity tests in a multidrug resistant human colonic 
adenocarcinoma cell line revealed that only the complex [Rh(5-
C5Me5)(H2curc)(H2O)]
+ shows similar anticancer activity compared to that of 
curcumin, the [Ru(6-arene)(H2O)3]2+ cations decrease this effect. It was also found 
that the interaction of these complexes with cell culture medium components and 
serum proteins results in decomposition of complexes. 1H NMR spectra indicate that 
the organometallic fragment is bound to amino acids and proteins. Upon the interaction 
with the model protein HSA decomposition of metal complexes and metal binding via 
the release of the ligand was detected. 
 
4. Experimental 
 
4.1. Chemicals 
All solvents were of analytical grade and used without further purification. [Rh(5-
C5Me5)(2-Cl)Cl]2, [Ru(6-p-cym)(2-Cl)Cl]2, curcumin (≥99.5%), acetylacetone, maltol, 
deferiprone, RuCl3 × 3H2O, KCl, AgNO3, HCl, KOH, 4,4-dimethyl-4-silapentane-1-sulfonic 
acid (DSS), HSA (as lyophilized powder with fatty acids, A1653), RPMI 1640, NaH2PO4, 
Na2HPO4, KH2PO4, toluene, ethanol and methanol were purchased from Sigma-Aldrich in 
puriss quality. Doubly distilled Milli-Q water was used for sample preparation. The dimeric 
ruthenium precursor [Ru(II)(6-tol)(2-Cl)Cl]2 was prepared according to literature 
procedures [38]. The exact concentration of the ligand stock solutions together with the 
proton dissociation constants were determined by pH-potentiometric titrations with the use of 
the computer program HYPERQUAD [51]. The aqueous [Rh(5-C5Me5)(H2O)3](NO3)2 stock 
solution was obtained by dissolving an exact amount of the dimeric precursor in water 
followed by the removal of chloride ions by addition of equivalent amounts of AgNO3. The 
exact concentrations of chloride ion containing and chloride free metal ion stock solutions 
were determined by pH-potentiometric titrations employing stability constants for [(Rh(5-
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C5Me5))2(2-OH)i](4-i)+, [(Ru(6-tol))2(2-OH)i](4-i)+ and [(Ru(6-p-cym))2(2-OH)i](4-i)+ (i = 2 
or 3) complexes [24,30].  
The stock solution of curcumin was prepared prior to the analysis on a weight-in-
volume basis dissolved in ethanol and kept in dark. HSA solution was freshly prepared before 
the experiments and its concentration was estimated from its UV absorption: 280 nm(HSA) = 
36850 M−1cm−1 [52]. It was dissolved in a modified phosphate buffered saline (PBS’) at pH 
7.40. PBS’ contains 12 mM Na2HPO4, 3 mM KH2PO4, 1.5 mM KCl and 100.5 mM NaCl; and 
the concentration of the K+, Na+ and Cl‒ ions corresponds to that of the human blood serum. 
 
4.2. Synthesis of the precursor [Ru(6-tol)(2-Cl)Cl]2 
[Ru(6-tol)(2-Cl)Cl]2 was prepared according the literature procedure used for the analogous 
[Ru(6-benzene)(2-Cl)Cl]2 [38] by adding 5 mL of 1-methyl-1,4-cyclohexadiene to a 
solution of 0.5 g RuCl3 × 3H2O (1.9 mmol) in 40 mL of absolute ethanol. This mixture was 
refluxed for 8 h. The reddish brown precipitate formed during the synthesis was filtered off, 
washed with diethyl ether and left to dry in exsiccator. Yield: 85%, 0.450 g; 1H NMR (500.26 
MHz, DMSO-d6, d, ppm): 2.12 (3H, s, CH3), 5.68 (3H, m, C2, C4, C6 toluene), 5.97 (2H, m, 
C3, C5 toluene); 13C NMR (125.79 MHz, DMSO-d6, d, ppm) 18.73 (CH3), 82.22 (C4 
toluene), 84.83 (C5, C3 toluene), 89.28 (C6, C2 toluene), 105.82 (C1 toluene). 
 
4.3. Crystallographic structure determination 
Single crystals suitable for X-ray diffraction experiment of compounds [Ru(6-tol)(acac)(Cl)] 
(1), and [Rh(5-C5Me5)(H2curc)(Cl)] × 2MeOH (2) were grown from MeOH or 
CH2Cl2/MeOH solution resulting in yellow and red single crystals, respectively. They were 
mounted on a loop and transferred to the goniometer. X-ray diffraction data were collected at 
-170 °C on a Rigaku RAXIS-RAPID II diffractometer using Mo-K radiation for crystal 1 
and Cu-K for crystal 2. A numerical absorption correction [53] was carried out in case of 
crystal 1 and a multi-scan absorption correction was used in case of crystal 2 using the 
software CrystalClear [54]. Sir2014 [55] and SHELXL [56] under WinGX [57] softwares 
were used for structure solution and refinement, respectively. The structures were solved by 
direct methods. The models were refined by full-matrix least squares on F2. Refinement of 
non-hydrogen atoms was carried out with anisotropic temperature factors. Hydrogen atoms 
were placed into geometric positions. They were included in structure factor calculations but 
they were not refined. The isotropic displacement parameters of the hydrogen atoms were 
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approximated from the U(eq) value of the atom they were bonded to. The summary of data 
collection and refinement parameters are collected in Table S1. Selected bond lengths and 
angles of compounds were calculated by PLATON software [58]. The graphical 
representation and the edition of CIF files were done by Mercury [59] and PublCif [60] 
softwares, respectively. The crystallographic data files for the complexes have been deposited 
with the Cambridge Crystallographic Database as CCDC 1882689 and 1882690. 
 
4.4. pH-Potentiometric measurements 
pH-Potentiometric measurements determining proton dissociation constants of ligands and 
overall stability constants for the metal complexes were carried out at 25.0 ± 0.1 °C in water 
and at a constant ionic strength of 0.20 M KCl. The titrations were performed in a carbonate-
free KOH solution (0.20 M). The exact concentrations of HCl and KOH solutions were 
determined by pH-potentiometric titrations. An Orion 710A pH-meter equipped with a 
Metrohm combined electrode (type 6.0234.100) and a Metrohm 665 Dosimat burette were 
used for the pH-potentiometric measurements. The electrode system was calibrated to the 
pH = −log[H+] scale by means of blank titrations (HCl vs. KOH), as suggested by Irving et al. 
[61]. The average water ionization constant, pKw, was determined as 13.76 ± 0.01 at 25.0 °C, 
I = 0.20 M (KCl), which is in accordance to literature [62]. The reproducibility of the titration 
points included in the calculations was within 0.005 pH units. The pH-potentiometric 
titrations were performed in the pH range between 2.0 and 11.5. The initial volume of the 
samples was 5.0 mL. The ligand concentration was 2.0 mM and was investigated at metal ion-
to-ligand ratios of 1:1, 1:1.5, and 1:2. The accepted fitting between the measured and 
calculated titration data points regarding the volume of the titrant was < 10 L. Samples were 
degassed by bubbling purified argon through them for about 10 minutes prior to the 
measurements and the inert gas was also passed over the solutions during the titrations. 
The computer program PSEQUAD [63] was utilized to establish the stoichiometry of 
the complexes and to calculate the overall stability constants. (MpLqHr) is defined for the 
general equilibrium: 
 
pM + qL + rH ⇌ MpLqHr; as (MpLqHr) = [MpLqHr]/([M]p[L]q[H]r) 
 
where M denotes the metal moiety [Rh(5-C5Me5)(H2O)3]2+ or [Ru(6-arene)(H2O)3]2+ and L 
the completely deprotonated ligand.  values for the various hydroxido complexes [(Rh(5-
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C5Me5))2(2-OH)i](4-i)+, [(Ru(6-tol))2(2-OH)i](4-i)+ and [(Ru(6-p-cym))2(2-OH)i](4-i)+ (i = 2 
or 3) were calculated based on the pH-potentiometric titration data and were found to be in 
good agreement with the previously published data [24,30]. 
 
4.5. UV-Vis spectrophotometric and 1H NMR measurements 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV-Vis 
spectra in the interval 200–800 nm. The path length (l) was 0.5, 1, or 2 cm. The proton 
dissociation constants of curcumin were determined spectrophotometrically by batch method 
to avoid the photodegradation. Samples contained 5 M curcumin and 5% (v/v) ethanol. UV-
Vis spectra were used to investigate the H2O/Cl
− exchange processes of complexes at 1 mM 
concentration, at pH 7.30 (20 mM phosphate buffer) as a function of chloride concentrations 
(0–300 mM).  
1H NMR studies were carried out on a Bruker Avance III HD 500 MHz instrument. 
All 1H NMR spectra were recorded with the WATERGATE water suppression pulse scheme 
using DSS internal standard. Acetylacetonate was dissolved in a 10% (v/v) D2O/H2O mixture 
to yield a concentration of 2 mM and was titrated at 25 °C, at I = 0.20 M (KCl) in absence or 
presence of [Rh(5-C5Me5)(H2O)3]2+ and [Ru(6-tol)(H2O)3]2+ at 1:1 metal-to-ligand ratio. 
Stability constants for the complexes were calculated by the computer program PSEQUAD 
[63]. 
 
4.6. Fluorescence and membrane ultrafiltration/UV-Vis studies with HSA 
Fluorescence spectra were recorded on a Hitachi-F4500 fluorimeter in 1 cm quartz cell at 25.0 
± 0.1 °C. All solutions were prepared in PBS’ (pH 7.40) and were incubated for 15 min or 24 
h. Samples contained 1 M HSA and various HSA-to-ligand or metal ion or metal complex 
ratios (from 1:0 to 1:10) were used. The excitation wavelength was 295 nm and the emission 
was read in the range of 305-450 nm. The quenching constant (log K’Q) was calculated with 
the computer program PSEQUAD [63] using the same approach applied in our previous 
works [28,29]. 
Samples were separated by ultrafiltration through 10 kDa membrane filters (Microcon 
YM-10 centrifugal filter unit, Millipore) in low (LMM) and high molecular mass (HMM) 
fractions with the help of a temperature controlled centrifuge (Sanyo, 10000/s, 10 min). 
Samples (0.50 mL) contained 50 M HSA and Rh(5-C5Me5) or its acac complex (150 M) 
in PBS’ buffer (pH 7.30) at 25.0 ± 0.1 °C and were incubated for 24 h. The LMM fraction 
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containing the non-bound metal complex was separated from the protein and its adducts in the 
HMM fraction. The concentration of the non-bound compounds in the LMM fractions was 
determined by UV-Vis spectrophotometry by comparing the recorded spectra to those of 
reference samples without the protein. When the complex decomposed due to the protein 
binding, free ligand was also detected in the LMM fraction. In this case the recorded spectra 
were deconvoluted using the molar absorbance spectra of the ligand and metal complex by 
Excel Solver (Microsoft Office 2007). 
 
4.7. Cell lines, culture conditions and cytotoxicity tests in cancer cell lines 
Cell lines and culture conditions: All cell culture reagents were obtained from Sigma-Aldrich 
and plastic ware from Sarstedt (Germany). Human colonic adenocarcinoma cell line Colo 
320/MDR-LRP multidrug resistant overexpressing ABCB1 (MDR1)-LRP (ATCC-CCL-
220.1) was purchased from LGC Promochem, Teddington, UK. The cells were cultured in 
RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-
glutamine, 1 mM sodium pyruvate and 100 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES). The cells were incubated at 37 °C, in a 5% CO2, 95% 
air atmosphere. The semi-adherent human colon cancer cells were detached with Trypsin-
Versene (EDTA) solution for 5 min at 37 °C. 
MTT assay: Curcumin and its premixed Rh(5-C5Me5) and Ru(6-arene) complexes  
were dissolved in an ethanol/PBS’ (1:1) mixture first, diluted in complete culture medium, 
then two-fold serial dilutions of compounds were prepared in 100 L of RPMI 1640, 
horizontally. The semi-adherent colonic adenocarcinoma cells were treated with Trypsin-
Versene (EDTA) solution. They were adjusted to a density of 1×104 cells in 100 L of RPMI 
1640 medium, and were added to each well, with the exception of the medium control wells. 
The final volume of the wells containing compounds and cells was 200 L.  
The culture plates were incubated at 37˚C for 24 h; at the end of the incubation period, 
20 L of MTT (Sigma) solution (from a stock solution of 5 mg/mL) were added to each well. 
After incubation at 37˚C for 4 h, 100 L of sodium dodecyl sulfate (SDS) (Sigma) solution 
(10% in 0.01 M HCI) were added to each well and the plates were further incubated at 37˚C 
overnight. Cell growth was determined by measuring the optical density (OD) at 540/630 nm 
with Multiscan EX ELISA reader (Thermo Labsystems, Cheshire, WA, USA). Inhibition of 
the cell growth (IC50) was determined according to the formula below: 
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Synopsis  
 
Solution stability of Ru(II)(6-toluene), Ru(II)(6-p-cymene) and Rh(III)(5-C5Me5) 
complexes of acetylacetone was determined in aqueous solution and compared with that of 
other (O,O) donor ligands. The structures of [Rh(III)(5-C5Me5)(H2curcumin)]+ and 
[Ru(II)(5-toluene)(acac)]+ were resolved by single crystal X-ray diffraction. Their 
cytotoxicity was evaluated in multidrug resistant human cancer cell lines. 
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Highlights 
 
► Solution stability of Ru(arene) and Rh(C5Me5) complexes of acac and curcumin  
► Acac is used as curcumin binding model 
► X-ray crystal structures of two complexes and comparison with analogous structures 
► Antiproliferative activity against multidrug resistant human cancer cell lines 
► Human serum albumin binding and interaction with cell culture medium components 
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